Results 311 to 320 of about 351,718 (359)
Some of the next articles are maybe not open access.
Hospital Practice, 1989
Bone marrow transplantation for treatment of certain hematologic and nonhematologic diseases is rapidly becoming the treatment of choice for a large number of patients. Over 10,000 marrow transplants have been performed, and over 200 marrow transplant units currently exist.
E H, Romond +7 more
+7 more sources
Bone marrow transplantation for treatment of certain hematologic and nonhematologic diseases is rapidly becoming the treatment of choice for a large number of patients. Over 10,000 marrow transplants have been performed, and over 200 marrow transplant units currently exist.
E H, Romond +7 more
+7 more sources
Critical Care Nursing Clinics of North America, 1992
BMT is an effective treatment for certain malignant and nonmalignant conditions. The source of the marrow is autologous or allogeneic. An allogeneic donor can be an HLA-matched related or unrelated donor. The patient undergoes intense chemoradiotherapy to remove remaining malignant cells and obliterate the immune system, thus allowing growth of the new
D, Wujcik, S, Downs
openaire +4 more sources
BMT is an effective treatment for certain malignant and nonmalignant conditions. The source of the marrow is autologous or allogeneic. An allogeneic donor can be an HLA-matched related or unrelated donor. The patient undergoes intense chemoradiotherapy to remove remaining malignant cells and obliterate the immune system, thus allowing growth of the new
D, Wujcik, S, Downs
openaire +4 more sources
Best Practice & Research Clinical Rheumatology, 1999
Some severe auto-immune diseases, including rheumatoid arthritis, require immunosuppression to save life or vital organ function. One major limiting factor in such immunosuppression is the unwanted and dangerous haematoablation occurring at the same time.
A, Tyndall, S, Millikan
openaire +2 more sources
Some severe auto-immune diseases, including rheumatoid arthritis, require immunosuppression to save life or vital organ function. One major limiting factor in such immunosuppression is the unwanted and dangerous haematoablation occurring at the same time.
A, Tyndall, S, Millikan
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 1985
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
BONE MARROW TRANSPLANTATION IN THALASSEMIA
Annual Review of Medicine, 1995▪ Abstract Early trials of allogeneic bone marrow transplantation (BMT) for homozygous β-thalassemia and the analyses of results of transplantation in patients less than 16 years old have allowed us to identify three classes of risk based on the following criteria: (a) hepatomegaly, (b) presence of liver fibrosis at histological examination, and (c ...
M.D Claudio Giardini +2 more
openaire +5 more sources
A History of Bone Marrow Transplantation
Immunology and Allergy Clinics of North America, 2010The last 40 years has seen the emergence of hematopoietic stem cell transplantation as a therapeutic modality for fatal diseases and as a curative option for individuals born with inherited disorders that carry limited life expectancy and poor quality of life.
Richard A. Gatti, M. Teresa de la Morena
openaire +5 more sources
The Indian Journal of Pediatrics, 1993
Bone marrow transplantations have a definite role in treatment of leukemias and lymphomas. In acute myeloid leukemia and CML an allogeneic transplant using an HLA identical donor certainly provides a far superior survival than chemotherapy. Patients with Ph' chromosome need to be transplanted in first remission if a suitable donor is available.
openaire +2 more sources
Bone marrow transplantations have a definite role in treatment of leukemias and lymphomas. In acute myeloid leukemia and CML an allogeneic transplant using an HLA identical donor certainly provides a far superior survival than chemotherapy. Patients with Ph' chromosome need to be transplanted in first remission if a suitable donor is available.
openaire +2 more sources
Transplantation of Chimeric Bone Marrow
International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1961SummaryRetransplantation of bone marrow was studied in an attempt to understand why foetal liver was superior to adult bone marrow in the treatment of lethally-irradiated mice.Presensitization experiments, in which recipients were immunized against cells of the future donor-strain, were performed.
Vos, O, Goodman, J W, Congdon, C C
openaire +4 more sources
Bone marrow transplantation retinopathy
International Ophthalmology, 2001Bone marrow transplantion (BMT) is the treatment of choice for both malignant and nonmalignant disorders of the bone marrow. BMT retinopathy occurs after a latent period of 6 months and usually recovers after a few weeks.We present a case of BMT retinopathy (BMT) in a patient with a high-degree of non-Hodgkin lymphoma.
María José Rodríguez-Cid +3 more
openaire +3 more sources
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987
Since the 1970s major progress in bone marrow transplantation has resulted in long‐term survival and even cure for many patients with serious hematologic disease. Many patients undergoing the procedure, however, experience serious complications, including graft rejection, graft‐versus‐host disease, and infection.
openaire +2 more sources
Since the 1970s major progress in bone marrow transplantation has resulted in long‐term survival and even cure for many patients with serious hematologic disease. Many patients undergoing the procedure, however, experience serious complications, including graft rejection, graft‐versus‐host disease, and infection.
openaire +2 more sources